Wellcome Trust
Status
ACTIVE
Global HQ
London, United Kingdom
Countries of investment
- United Kingdom
- United States
- Germany
- France
Investment stages
- Series B
- Series C
- Growth
Industries
- Biotechnology
- Health & Wellness
About
The Wellcome Trust is one of the largest investors in global health and life-science ventures, focusing on later-stage companies with scalable impact. The firm looks for companies that have demonstrated strong clinical evidence and the potential to address significant global health challenges. Wellcome Trust provides long-term funding and operational support to ensure these companies can scale, create durable moats, and generate positive outcomes for patients worldwide.
The Wellcome Trust is one of the largest investors in global health and life-science ventures, focusing on later-stage companies with scalable impact. The firm looks for companies that have demonstrated strong clinical evidence and the potential to address significant global health challenges. Wellcome Trust provides long-term funding and operational support to ensure these companies can scale, create durable moats, and generate positive outcomes for patients worldwide.
Investment Thesis
Wellcome Trust’s thesis is to invest in later-stage health and life-science ventures that address major global health challenges. It targets companies with validated clinical efficacy and scalable impact, aiming to create sustainable solutions that improve healthcare access and outcomes worldwide.
Manager's Experience
Managed by a philanthropic foundation with deep expertise in healthcare and biotech investing, focused on advancing life sciences innovation globally.
Team
John-Arne Røttingen – CEO
Maggy Chan – COO
Mark Henderson – Exec Dir
Corporate Affairs
Rachel McKendry – Exec Role
Charlotte Watts – Exec Role.
Portfolio
Syncona
Cambridge Epigenetix
NightstaRx
Cultivarium